Anti-CD3 × Anti-HER2 Bispecific Antibody Effectively Redirects Armed T Cells to Inhibit Tumor Development and Growth in Hormone-Refractory Prostate Cancer–Bearing Severe Combined Immunodeficient Beige Mice - Concepedia

Concepedia

Publication | Closed Access

Anti-CD3 × Anti-HER2 Bispecific Antibody Effectively Redirects Armed T Cells to Inhibit Tumor Development and Growth in Hormone-Refractory Prostate Cancer–Bearing Severe Combined Immunodeficient Beige Mice

39

Citations

26

References

2004

Year

Pamela A. Davol, Janelle A. Smith, Nicola Kouttab, Gerald J. Elfenbein, Lawrence G. Lum

Clinical Prostate Cancer

Tumor ImmunologyCancer ImmunosurveillanceImmunologyTumor ImmunityT Cell ImmunityImmunotherapeuticsCell TransplantationInhibit Tumor DevelopmentCellular Immune ResponseImmunotherapyMedicineRadiation Oncology

References

	Year	Citations

Page 1